Subtitle
FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach.
Subtitle
FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach.
Proto therapy Time
March 2024
Executive summary
This is a trial protocol of FAST-02. This trial includes 10 patients with 1-3 painful bone metastases in the thorax, excluding bone metastases in the spine. Treatment will be 8 Gy in a single fraction administered at ≥ 40 Gy/s on a FLASH-enabled proton therapy system delivering a single transmission proton beam. Primary study endpoints are efficacy (pain relief) and safety. Registration: ClinicalTrials.gov NCT05524064.
Key content topics
Top cancer treatments
Related contents
Proton Therapy Publication
October 2024
The Radiosurgery Society Working Groups on GRID, LATTICE, Microbeam, and FLASH Radiotherapies: 2022 - 2023 Advancements Symposium and Subsequent Progress Made.
Proton Therapy Publication
September 2024
The Potential and Challenges of Proton FLASH in Head and Neck Cancer Reirradiation.
Proton Therapy Publication
June 2024
Navigating the Critical Translational Questions for Implementing FLASH in the Clinic.
Proton Therapy Publication
April 2024
FLASH Radiotherapy: What Can FLASH's Ultra High Dose Rate Offer to the Treatment of Patients With Sarcoma?
Proton Therapy Publication
April 2024
Proton FLASH radiotherapy ameliorates radiation-induced salivary gland dysfunction and oral mucositis and increases survival in a mouse model of head and neck cancer.
Webinar
April 25, 2024
Translating ConformalFLASH® from Research to Reality
Yohan
Godart
Michele
Kim
Jarrick
Nys
Proton Therapy Publication
January 2021
FLASH Radiotherapy: Current Knowledge and Future Insights Using Proton-Beam Therapy.